FY2024 EPS Estimates for Allstate Lifted by Zacks Research

The Allstate Co. (NYSE:ALL - Free Report) - Research analysts at Zacks Research boosted their FY2024 EPS estimates for Allstate in a report released on Wednesday, December 18th. Zacks Research analyst Z. Masood now expects that the insurance provider will earn $15.46 per share for the year, up from their prior forecast of $15.42. The consensus estimate for Allstate's current full-year earnings is $16.26 per share. Zacks Research also issued estimates for Allstate's Q4 2024 earnings at $4.81 EPS, Q1 2025 earnings at $5.12 EPS, Q2 2025 earnings at $2.95 EPS, Q3 2025 earnings at $3.93 EPS, Q4 2025 earnings at $4.70 EPS, FY2025 earnings at $16.70 EPS, Q1 2026 earnings at $5.20 EPS, Q3 2026 earnings at $4.70 EPS and FY2026 earnings at $18.33 EPS.

Allstate (NYSE:ALL - Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, beating analysts' consensus estimates of $2.20 by $1.71. Allstate had a net margin of 6.77% and a return on equity of 26.67%. The firm had revenue of $16.63 billion during the quarter, compared to the consensus estimate of $14.57 billion. During the same quarter last year, the firm earned $0.81 EPS. The firm's revenue for the quarter was up 14.7% compared to the same quarter last year.

Several other analysts have also weighed in on ALL. UBS Group increased their price target on Allstate from $216.00 to $225.00 and gave the company a "buy" rating in a report on Monday, November 4th. The Goldman Sachs Group raised their target price on shares of Allstate from $209.00 to $230.00 and gave the stock a "buy" rating in a report on Friday, November 15th. Bank of America lifted their price target on shares of Allstate from $216.00 to $233.00 and gave the stock a "buy" rating in a research note on Friday, October 18th. Piper Sandler increased their price objective on shares of Allstate from $206.00 to $244.00 and gave the stock an "overweight" rating in a research report on Tuesday, November 26th. Finally, Keefe, Bruyette & Woods boosted their target price on Allstate from $222.00 to $225.00 and gave the company an "outperform" rating in a research report on Wednesday, November 6th. One analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $217.19.

Allstate Trading Up 2.0 %

Shares of NYSE:ALL traded up $3.77 during trading on Friday, hitting $193.56. The company had a trading volume of 2,351,391 shares, compared to its average volume of 1,551,107. The stock has a market cap of $51.26 billion, a price-to-earnings ratio of 12.54, a price-to-earnings-growth ratio of 1.70 and a beta of 0.50. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.40 and a quick ratio of 0.40. The company has a fifty day simple moving average of $195.72 and a two-hundred day simple moving average of $182.25. Allstate has a one year low of $134.17 and a one year high of $209.88.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. State Street Corp boosted its stake in Allstate by 1.1% in the third quarter. State Street Corp now owns 11,496,306 shares of the insurance provider's stock valued at $2,190,758,000 after acquiring an additional 126,922 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Allstate by 1.2% in the third quarter. Geode Capital Management LLC now owns 6,228,581 shares of the insurance provider's stock worth $1,178,164,000 after buying an additional 74,537 shares during the last quarter. Allspring Global Investments Holdings LLC grew its holdings in Allstate by 18.7% during the third quarter. Allspring Global Investments Holdings LLC now owns 3,000,866 shares of the insurance provider's stock worth $569,114,000 after acquiring an additional 472,040 shares during the period. Raymond James & Associates raised its position in Allstate by 10.6% during the third quarter. Raymond James & Associates now owns 1,517,800 shares of the insurance provider's stock valued at $287,851,000 after acquiring an additional 145,986 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its holdings in Allstate by 3.4% in the second quarter. Dimensional Fund Advisors LP now owns 1,437,688 shares of the insurance provider's stock valued at $229,545,000 after acquiring an additional 47,038 shares during the period. 76.47% of the stock is currently owned by institutional investors.

Allstate Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, January 2nd. Investors of record on Friday, November 29th will be issued a $0.92 dividend. The ex-dividend date of this dividend is Friday, November 29th. This represents a $3.68 annualized dividend and a dividend yield of 1.90%. Allstate's payout ratio is currently 23.83%.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.